Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Cancer Research|December 10, 2014
Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasisJelena Stanisavljevic, Jordina Loubat-Casanovas, Mercedes Herrera, et al.
International Journal of Molecular Sciences|February 25, 2023
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast CancerSandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, et al.
Molecular Medicine (Cambridge, Mass.)|March 26, 2025
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancerAna Lameirinhas, Sandra Torres-Ruiz, Iris Garrido-Cano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancerMiguel A Molina, Rosana Sáez, Elizabeth E Ramsey, et al.
Biomaterials Research|April 10, 2026
Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast CancerAna Lameirinhas, Paula Díez, Francisco J Hicke, et al.
International Journal of Molecular Sciences|October 14, 2020
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast CancerIris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, et al.
Cancer Communications (London, England)|August 23, 2022
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studiesIris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
BMC Cancer|March 11, 2014
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II studyThomas Bachelot, Jose A Garcia-Saenz, Sunil Verma, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 13, 2022
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overviewJuan C Vázquez, Antonio Piñero, Francisco Javier de Castro, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Cancer Research|December 10, 2014
Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasisJelena Stanisavljevic, Jordina Loubat-Casanovas, Mercedes Herrera, et al.
International Journal of Molecular Sciences|February 25, 2023
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast CancerSandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, et al.
Molecular Medicine (Cambridge, Mass.)|March 26, 2025
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancerAna Lameirinhas, Sandra Torres-Ruiz, Iris Garrido-Cano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancerMiguel A Molina, Rosana Sáez, Elizabeth E Ramsey, et al.
Biomaterials Research|April 10, 2026
Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast CancerAna Lameirinhas, Paula Díez, Francisco J Hicke, et al.
International Journal of Molecular Sciences|October 14, 2020
Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast CancerIris Garrido-Cano, Vera Constâncio, Anna Adam-Artigues, et al.
Cancer Communications (London, England)|August 23, 2022
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studiesIris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
BMC Cancer|March 11, 2014
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II studyThomas Bachelot, Jose A Garcia-Saenz, Sunil Verma, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 13, 2022
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overviewJuan C Vázquez, Antonio Piñero, Francisco Javier de Castro, et al.
Pageof 19